These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32575806)
1. Multimodal Imaging in the Management of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy. Hagag AM; Chandra S; Khalid H; Lamin A; Keane PA; Lotery AJ; Sivaprasad S J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575806 [TBL] [Abstract][Full Text] [Related]
2. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography. Bonini Filho MA; de Carlo TE; Ferrara D; Adhi M; Baumal CR; Witkin AJ; Reichel E; Duker JS; Waheed NK JAMA Ophthalmol; 2015 Aug; 133(8):899-906. PubMed ID: 25996386 [TBL] [Abstract][Full Text] [Related]
3. Nonhomogenous Hyperreflectivity in the Choriocapillaris Layer on Optical Coherence Tomography Angiography Implies Early Treatment with Anti-VEGF for Central Serous Chorioretinopathy. Zhao Z; Zhang J Ophthalmic Res; 2022; 65(5):506-515. PubMed ID: 35405684 [TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Anti-VEGF Therapy for Putative or Visible CNV in Central Serous Chorioretinopathy by Optical Coherence Tomography Angiography. Zhang Y; Zhang J; Sun X J Ophthalmol; 2022; 2022():1272524. PubMed ID: 36211595 [TBL] [Abstract][Full Text] [Related]
8. Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents. Schworm B; Luft N; Keidel LF; Hagenau F; Kern C; Herold T; Kortuem KU; Priglinger SG; Siedlecki J Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1013-1021. PubMed ID: 32112141 [TBL] [Abstract][Full Text] [Related]
9. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy. Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761 [TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy. Liu T; Lin W; Zhou S; Meng X Br J Ophthalmol; 2021 Feb; 105(2):233-238. PubMed ID: 32265200 [TBL] [Abstract][Full Text] [Related]
11. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Bousquet E; Bonnin S; Mrejen S; Krivosic V; Tadayoni R; Gaudric A Retina; 2018 Mar; 38(3):629-638. PubMed ID: 28267114 [TBL] [Abstract][Full Text] [Related]
12. Correlation between Choroidal Neovascularization Shown by OCT Angiography and Choroidal Thickness in Patients with Chronic Central Serous Chorioretinopathy. Gołębiewska J; Brydak-Godowska J; Moneta-Wielgoś J; Turczyńska M; Kęcik D; Hautz W J Ophthalmol; 2017; 2017():3048013. PubMed ID: 29109866 [TBL] [Abstract][Full Text] [Related]
15. Vascularization of Irregular Retinal Pigment Epithelial Detachments in Chronic Central Serous Chorioretinopathy Evaluated With OCT Angiography. de Carlo TE; Rosenblatt A; Goldstein M; Baumal CR; Loewenstein A; Duker JS Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):128-33. PubMed ID: 26878445 [TBL] [Abstract][Full Text] [Related]
16. RETROSPECTIVE ANALYSIS OF THE PRESENCE OF CHOROIDAL NEOVASCULARISATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY WITH THE AID OF PHOTODYNAMIC THERAPY. Myslík Manethová K; Ernest J Cesk Slov Oftalmol; 2021; 77(3):122-131. PubMed ID: 35130703 [TBL] [Abstract][Full Text] [Related]
17. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ferrara D; Mohler KJ; Waheed N; Adhi M; Liu JJ; Grulkowski I; Kraus MF; Baumal C; Hornegger J; Fujimoto JG; Duker JS Ophthalmology; 2014 Mar; 121(3):719-26. PubMed ID: 24289918 [TBL] [Abstract][Full Text] [Related]
18. Optical Coherence Tomography Angiography in Eyes with Indeterminate Choroidal Neovascularization: Results from the AVATAR study. Uchida A; Manjunath D; Singh RP; Rachitskaya AV; Kaiser PK; Srivastava SK; Reese JL; Ehlers JP Ophthalmol Retina; 2018 Nov; 2(11):1107-1117. PubMed ID: 30662973 [TBL] [Abstract][Full Text] [Related]
19. Optical Coherence Tomography Angiography Compared with Multimodal Imaging for Diagnosing Neovascular Central Serous Chorioretinopathy. Ng DS; Ho M; Chen LJ; Yip FL; Teh WM; Zhou L; Mohamed S; Tsang CW; Brelén ME; Chen H; Pang CP; Lai TYY Am J Ophthalmol; 2021 Dec; 232():70-82. PubMed ID: 34116008 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy. Smretschnig E; Hagen S; Glittenberg C; Ristl R; Krebs I; Binder S; Ansari-Shahrezaei S Eye (Lond); 2016 Jun; 30(6):805-11. PubMed ID: 26965012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]